Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: J Subst Abuse Treat. 2021 Jan 29;128:108315. doi: 10.1016/j.jsat.2021.108315

Table 1:

Study measurements for TCN PATHS study

Domain Components/method of assessment/measurement instrumenta When Assessed Purpose
Demographic Age, sex, race, ethnicity, marital status, level of education BL Covariate
Residential data
distance to nearest OTP, buprenorphine prescriber, community health center
Zip Code 1, 6, 12 months Covariate
Health
Medical and mental health comorbidities
History of OUD and MOUD treatment
List of medical and mental health conditions BL Covariate
Addiction severity, use of other illicit drugs, and trauma Self-report BL, 1, 6, 12 months Covariate
Wellbeing/quality of life, pain, and depression symptoms
Discrimination
Self-report via PROMIS 29+2/PROPr instrument

Self-report via Everyday Discrimination Scale (short version)
BL, 1, 6 and 12 months Secondary outcome
Opioid Use Disorder treatment cascade and related outcomes
Engagement in OUD treatment
Retention in OUD treatment
Retention on MOUD

Illicit opioid use: # of days of use in the past month
Self-report confirmed with electronic health record or treatment facility



Self-report using TimeLine FollowBack; urine toxicology positive for illicit opioids
1 month



1, 3, 6, 9 and 12 months
Primary Outcome
Overdose Self-report; electronic health record BL, 1, 3, 6, 9, 12 months Secondary Outcome Cost analysis
Death Electronic health record 1, 6, 12 months Secondary Outcome; CEA
Health Care Utilization and Experience
Drug Abuse Treatment Cost Analysis Program Self-report 1, 6 and 12 months CEA
Primary Care Engagement, Acute care utilization Self-report; electronic health record 1, 3, 6, 9, 12 months Secondary Outcome; CEA
Social determinants of health
Housing stability
Food insecurity
Social support

Criminal Justice Contact
Self-report;



Self-report; criminal justice contact confirmed via Department of Corrections data
1, 3, 6, 9, 12 months Putative mediator;



Putative mediator and CEA
Psychosocial factors
Self-stigma Self-report BL, 1, 6 and 12 months after release; Covariate Cost Analysis (QOL)
Policy measures
Criminal Justice System Policies
Collateral consequences
Access to MOUD in halfway house, Access to naloxone, Access to benefits; Housing, food stamp, licensure bans 1, 6, 12 months Covariate
a

- validated instruments used are listed where applicable

Legend: BL = Baseline assessment, OTP = Opioid Treatment Program, OUD = Opioid Use Disorder, MOUD = Medications for Opioid Use Disorder, CEA = Cost effectiveness Analysis, QOL - Quality of Life